Aug 31, 2017

Stem cells can replace nerves damaged by Parkinson's in monkeys

Dopaminergic neurons; Photo: Kyoto University

A Kyoto University research team says it successfully used neurons created from stem cells to replace neurons damaged by Parkinson's disease in monkeys.

What they found: The five-year study found transplanted neurons could survive long-term and restore movement control with minimal side effects, the scientists said. They report their results were improved by matching proteins in the grafted tissue with proteins in the recipient and using mild immunosuppressants.

Why this is important: Among other problems, Parkinson's disease, which affects roughly one million Americans, causes neurons to degenerate and die. As a result, nerve cells can't communicate with muscles properly. While drugs can help alleviate symptoms temporarily, researchers are searching for ways to halt the degenerative aspect of the disease. There is renewed interest in using stem cell research after a halt years ago due to a lack of success and painful side effects.

"These findings are important because it [offers] strong evidence that these cells are clinically applicable," Jun Takahashi, study author from Kyoto University told Axios.

Yes, but: The NIH's Mark Cookson, who wasn't involved in the research, points out that while there may be merit in moving forward with stem cell therapy research to see how it does in human trials, he does not think this will become the main therapeutic avenue for most Parkinson's patients due to cost and that it does not treat all the disease's symptoms, which can include dementia and falls.

"Despite the technical achievements here, the procedures are going to be more complex and expensive than mainstay symptomatic treatments like L-DOPA [a drug called Levodopa used to manage symptoms] and surgical approaches such as deep brain stimulation," Mark Cookson, cell biologist at the NIH's Laboratory of Neurogenetics, told Axios. "Perhaps more importantly, these targeted approaches will not address non-dopaminergic/non-motor aspects of PD which are very problematic for many patients. All of those concerns were concerns when stem cell therapies stopped being chased as heavily and I don't think those have changed."

Tilo Kunath, a neurologist at the MRC Centre for Regenerative Medicine who was not part of this study, said it was "extremely promising research," according to a Science Media Centre roundup of expert opinion. "Such therapy has the potential to reverse the symptoms of Parkinson's in patients by restoring their dopamine-producing neurons," Kunath said in the release.

The details: The research team first injected monkeys with a neurotoxin over a period of time until the animals consistently showed typical Parkinson's symptoms including tremors, bradykinesia, and impaired balance for at least 12 weeks. They created dopaminergic neurons from adult human cells that were reprogrammed to become capable of differentiating into a range of different cells, similar to stem cells. They then grafted the cells into the brains of Parkinson's disease-affected monkeys and observed the animals for two years after the transplantation.

Go deeper

CDC: Coronavirus antibodies could give "short-term immunity," but more data is needed

CDC Director Robert Redfield briefs reporters on April 8. Photo: Mandel Ngan/AFP via Getty Images

Coronavirus antibody tests are still relatively unreliable, and scientists still aren't sure whether people who get the virus are immune to getting it again, the Centers for Disease Control and Prevention cautioned on Tuesday.

What they're saying: The agency explicitly warned against using antibody tests to determine whether someone should return to work or to group people within schools or prisons.

Trump accuses Twitter of interfering in 2020 election

President Trump speaks to the press as he departs the White House in Washington, D.C., on Thursday. Photo: Mandel Ngan/Getty Images

President Trump responded via tweets Tuesday evening to Twitter fact-checking him for the first time on his earlier unsubstantiated posts claiming mail-in ballots in November's election would be fraudulent.

What he's saying: "Twitter is now interfering in the 2020 Presidential Election.They are saying my statement on Mail-In Ballots, which will lead to massive corruption and fraud, is incorrect, based on fact-checking by Fake News CNN and the Amazon Washington Post," the president tweeted. "Twitter is completely stifling FREE SPEECH, and I, as President, will not allow it to happen!"

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 8:30 p.m. ET: 5,584,091 — Total deaths: 349,894 — Total recoveries — 2,284,242Map.
  2. U.S.: Total confirmed cases as of 8:30 p.m. ET: 1,680,301 — Total deaths: 98,875 — Total recoveries: 384,902 — Total tested: 14,907,041Map.
  3. Federal response: DOJ investigates meatpacking industry over soaring beef pricesMike Pence's press secretary returns to work.
  4. Congress: House Republicans to sue Nancy Pelosi in effort to block proxy voting.
  5. Business: How the new workplace could leave parents behind.
  6. Tech: Twitter fact-checks Trump's tweets about mail-in voting for first timeGoogle to open offices July 6 for 10% of workers.
  7. Public health: CDC releases guidance on when you can be around others after contracting the coronavirus.
  8. What should I do? When you can be around others after contracting the coronavirus — Traveling, asthma, dishes, disinfectants and being contagiousMasks, lending books and self-isolatingExercise, laundry, what counts as soap — Pets, moving and personal healthAnswers about the virus from Axios expertsWhat to know about social distancingHow to minimize your risk.
  9. Other resources: CDC on how to avoid the virus, what to do if you get it, the right mask to wear.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.

Updated 44 mins ago - Politics & Policy